Congress funds fentanyl prevention—but bars some harm-reduction supplies
H.R. 5573 — Combatting Fentanyl Poisonings Act of 2025 · Filed by Gabe Evans (R-CO) · 12 cosponsors · Introduced Sep 26, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates three new federal grant programs under the Omnibus Crime Control and Safe Streets Act to combat fentanyl poisonings: (1) grants to state and local law enforcement to run social-media-focused drug enforcement and education programs; (2) grants to nonprofits for public awareness campaigns about fentanyl dangers, including support for bereaved families and naloxone training; and (3) grants to law enforcement for fentanyl-detection equipment and officer training. The bill appropriates $15 million total ($10M, $3M, $2M respectively) and explicitly bars the nonprofit grants from funding harm-reduction supplies like sterile injection kits, except naloxone.
Why we flagged it
The bill's operative mechanism is straightforward: it creates three federal grant programs funded by direct appropriations to address fentanyl poisoning through law enforcement, public education, and officer safety. No tax carve-outs, no liability shields, no private-sector giveaways—just public funding for public-health and law-enforcement purposes.
What the text implies
- The explicit prohibition on harm-reduction supplies (except naloxone) may limit nonprofit grantees' ability to implement evidence-based overdose-prevention strategies, potentially reducing the public-health effectiveness of the awareness-campaign grants.
- The $50,000 cap on individual nonprofit grants may limit the scale and reach of awareness campaigns, particularly in high-burden communities.
- Law enforcement focus on social-media drug sales may shift enforcement resources away from other fentanyl-distribution channels (dark web, street-level trafficking, pharmaceutical diversion).
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill funds public education, family support services, and law enforcement tools to address a genuine public-health crisis (fentanyl overdose deaths). The exclusion of certain harm-reduction supplies is a policy trade-off, but the core mechanisms—education, naloxone access, officer safety—serve broad public health and safety interests without creating private monopolies or liability shields.
Who stands to gain
- state and local law enforcement agencies
- nonprofit organizations (501(c)(3))
- manufacturers of fentanyl-detection equipment and naloxone
Named in the bill
Attorney General, Bureau of Justice Assistance, Secretary of Health and Human Services, State and local law enforcement agencies, Nonprofit organizations (501(c)(3)), Omnibus Crime Control and Safe Streets Act of 1968, Controlled Substances Act
Where it stands
12 cosponsors: 6 Democrats, 6 Republicans.
- Sep 26, 2025 — Introduced · Congress.gov: “Introduced in House”
- Sep 26, 2025 — Referred to House Committee on the Judiciary · Congress.gov: “Referred to the House Committee on the Judiciary”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 3 disclosure filings across 3 quarters, Mar 2026 to Sep 2026. Those filings disclosed $150,000 in lobbying spend. A filing names 85 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Gabe Evans, the sponsor, reported $1,670,967 in PAC receipts in the 2026 cycle.
- Peace Officers Research Association of California — $150,000 on 3 filings
Lobbying Disclosure Act filings through Oct 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (5,406 characters) on Nov 14, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Mar 2026 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Oct 20, 2026 · page rendered 2026-11-22.
“Congress funds fentanyl prevention—but bars some harm-reduction supplies” QuorumCivic. https://share.quorumcivic.app/bill/119/hr5573 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.